Investor Profile: 2048 Ventures — Thesis, Cheque Size & How to Apply

2048 Ventures is a New York and Boston venture firm with a clear self-description: the first-check, highest-conviction lead investor in technology startups with strong data moats. Founded by Alex Iskold, a five-time founder and former managing director of Techstars New York, the firm invests through a thesis-driven lens, leading pre-seed and seed rounds rather than following them.

The thesis is built on data. 2048 Ventures believes generational companies unlock moats and scale through data, and it studies business models and mechanics before it invests. Its current focus spans four areas: vertical artificial intelligence, deep technology, healthcare and biotechnology. In deep technology, it watches video as a new system of record, low-cost sensors, drones, robotics and physical AI. In healthcare, its thesis centres on real-time measurement and orchestration of care. In biotechnology, it focuses on infrastructure and differentiated intellectual property.

Fund size is publicly documented. 2048 Ventures closed an oversubscribed $82,048,000 Fund III, its third and largest fund after a $27 million Fund I in 2019 and a $67 million Fund II in 2022. Fund III is led by general partners Alex Iskold, Zann Ali and Julie Wolf, a former IndieBio chief science officer. The firm leads pre-seed and seed rounds with cheques of $500K to $3M, investing primarily in New York City and Boston.

The portfolio shows the thesis in action. First-check investments include GlossGenius, a platform for the beauty industry; Gorgias, DataCamp, Mantl and BentoBox; Healthie; and Aerodome, acquired by Flock Safety. In healthcare and biotechnology, it has backed Impilo, infrastructure for remote patient monitoring; Century Health, a marketplace for longitudinal data; Nomic, a large protein profiling platform; Persist AI, automation infrastructure for drug formulation; and TwoStep Therapeutics, a Stanford spinout focused on drug delivery to solid tumours. The firm reports a founder net promoter score of 100, seven years in a row.

Programmes give founders a faster route in. 2048 Ventures launched Pre-Seed Fast Track, described as one of the industry's fastest paths for founders raising up to $1.5 million, with the entire process, from first meeting to money in the bank, taking no more than 10 business days. It also runs a Fellowship Program giving students exposure to venture investing, embedded in the New York and Boston academic ecosystems, including Harvard, MIT, Yale, NYU and Cornell Tech.

On credits and perks, 2048 Ventures publishes no formal perks catalogue. Its value-add is the lead cheque, the thesis-driven diligence, and the speed of Pre-Seed Fast Track. Founders should read its published theses first: the firm is explicit that it backs exceptional, ultra-competitive, visionary founders.

How to apply for funding

Founders can pitch 2048 Ventures directly through its official website, 2048.vc, with no warm introduction required. The fastest route is Pre-Seed Fast Track, for founders raising up to $1.5 million, which promises a decision and funding within 10 business days. A strong pitch shows a data moat in the making and names the thesis it fits: vertical AI, deep tech, healthcare or biotech.